News | October 09, 2022
BioMarin simplifies organizational structure to increase efficiency
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
Dr. Pedrocchi is currently an Independent Strategic Advisor and Non-Executive Director to private and public healthcare companies.
A primary investment of Rs 194.4 crore has been made
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
The CAS SciFinder Discovery Platform expansion unlocks human-indexed insights from journals and patents in over 50 languages dating back to 1957 and 70 million biosequences curated by CAS scientists
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
